Literature DB >> 30953289

Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Update and Diagnostic Considerations-a Review.

Esther Diana Rossi1, William C Faquin2, Zubair Baloch3, Guido Fadda4, Lester Thompson5, Luigi Maria Larocca4, Liron Pantanowitz6.   

Abstract

Advances in our understanding of thyroid lesions, especially those entities with an indolent behavior, has led clinicians to question the most appropriate surgical management of such thyroid nodules. Several studies have shown that the non-invasive encapsulated follicular variant of papillary thyroid carcinomas (NI-EFVPC) exhibits poor histopathologic diagnostic reproducibility and have been over-treated as conventional thyroid cancer. In 2015, an international thyroid working group re-evaluated NI-EFVPC and its diagnostic criteria. The new terminology of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" (NIFTP) was accordingly introduced to replace NI-EFVPC. The literature has emphasized that NIFTPs are biologically similar to follicular adenomas lacking lymph node metastases and/or recurrence. While the definition of NIFTP is based on specific morphological parameters, recent studies have questioned whether the criterion allowing less than 1% of true papillae should be revised to a total absence of papillae. The motivation for this revision is the rare finding, in some studies, of lymph nodes with metastatic NIFTP. This review evaluates the existing published series of NIFTP cases, clinical consequences of NIFTP, and emerging changes in the diagnostic criteria for NIFTP. The introduction of NIFTP has resulted in significant impact on the clinical management of thyroid nodules. Recent revisions in the morphological criteria for NIFTP emphasize the need to adhere to very stringent histomorphologic criteria when making a diagnosis of NIFTP. The adoption of NIFTP terminology instead of NI-EFVPC is associated with conservative lobectomy without radioactive iodine treatment in the majority of cases.

Entities:  

Keywords:  Follicular variant of PTC; Molecular testing; NIFTP; Papillary thyroid carcinoma; Personalized medicine; Thyroid cytology

Year:  2019        PMID: 30953289     DOI: 10.1007/s12022-019-9574-7

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  6 in total

Review 1.  Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Diagnostic updates and molecular advances.

Authors:  Ying-Hsia Chu; Peter M Sadow
Journal:  Semin Diagn Pathol       Date:  2020-06-10       Impact factor: 3.464

2.  Three ultrasound phenotypes of non-invasive follicular thyroid neoplasm with papillary-like nuclear features proposed for imaging-pathology analysis: single center experience.

Authors:  Ruifeng Liu; Luying Gao; Yu Xia; Xiaoyi Li; Quan Liao; Ying Jiang; Qing Zhang; Cheng Chen; Li Zhang; Zhiyong Liang; Yuxin Jiang
Journal:  Gland Surg       Date:  2021-01

3.  HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.

Authors:  Qandeel Sadiq; Radhika Sekhri; Daniel T Dibaba; Qi Zhao; Shweta Agarwal
Journal:  World J Surg Oncol       Date:  2021-05-08       Impact factor: 2.754

4.  Clinical-pathological issues in thyroid pathology: study on the routine application of NIFTP diagnostic criteria.

Authors:  Valentina Canini; Davide Leni; Angela Ida Pincelli; Marcella Scardilli; Mattia Garancini; Chiara Villa; Camillo Di Bella; Giulia Capitoli; Riccardo Cimini; Biagio Eugenio Leone; Fabio Pagni
Journal:  Sci Rep       Date:  2019-09-12       Impact factor: 4.379

5.  What you see might not be what you get: Analysis of 15 prospective cases of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).

Authors:  Mohamed S Al Hassan; Walid El Ansari; Hamzah El Baba; Mahir Petkar; Abdelrahman Abdelaal
Journal:  Int J Surg Case Rep       Date:  2022-01-05

6.  Thyroid Bethesda Category AUS/FLUS in Our Microscopes: Three-Year-Experience and Cyto-Histological Correlation.

Authors:  Roope Huhtamella; Ivana Kholová
Journal:  Cancers (Basel)       Date:  2019-10-28       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.